Maintaining Hold on Inspire Medical Systems Amid Solid Q2 Performance and Cautious H2 Revenue Outlook
Inspire Medical Systems Price Target Maintained With a $260.00/Share by RBC Capital
Inspire Medical Systems Analyst Ratings
Baird Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $200
Inspire Medical Systems: Hold Rating Amidst Strong Financials and Emerging Market Uncertainties
Analysts Offer Insights on Healthcare Companies: Inspire Medical Systems (INSP), Definitive Healthcare Corp (DH) and Bicycle Therapeutics (BCYC)
KeyBanc Remains a Buy on Inspire Medical Systems (INSP)
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Maintaining Hold on Inspire Medical Systems Amid Policy Changes and Market Volatility
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Inspire Medical Systems: Solid Q2 Performance Leads to Hold Rating Amid Balanced Risk/Reward
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Buy Rating
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $187
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Lake Street Sticks to Their Buy Rating for Inspire Medical Systems (INSP)
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Inspire Medical Systems (INSP) Gets a Buy From Lake Street
Truist Cuts Price Target on Inspire Medical Systems to $217 From $280, Maintains Buy Rating
Inspire Medical Systems Analyst Ratings